Fluorouracil News and Research

RSS
Fluorouracil is a drug used to treat symptoms of cancer of the colon, breast, stomach, and pancreas. It is also used in a cream to treat certain skin conditions. Fluorouracil stops cells from making DNA and it may kill cancer cells. It is a type of antimetabolite. Also called 5-fluorouracil and 5-FU.
Combination chemotherapy confirmed viable for penile cancer

Combination chemotherapy confirmed viable for penile cancer

Study examines whether eribulin offers added benefit to women with breast cancer

Study examines whether eribulin offers added benefit to women with breast cancer

Healthcare professionals receive SingHealth Duke-NUS Scientific Congress abstract awards

Healthcare professionals receive SingHealth Duke-NUS Scientific Congress abstract awards

Sanofi-aventis receives FDA approval for Zaltrap to treat colorectal cancer

Sanofi-aventis receives FDA approval for Zaltrap to treat colorectal cancer

Scientists discover new way to combat post-surgical scarring for glaucoma patients

Scientists discover new way to combat post-surgical scarring for glaucoma patients

New association found between basal cell carcinoma and eczema

New association found between basal cell carcinoma and eczema

Chemotherapy improves survival for patients with periampullary cancer following resection

Chemotherapy improves survival for patients with periampullary cancer following resection

FDA approves KRAS gene mutation test for colorectal cancer

FDA approves KRAS gene mutation test for colorectal cancer

No benefits to polychemotherapy after surgery in gastric cancer

No benefits to polychemotherapy after surgery in gastric cancer

Precision Therapeutics’ ChemoFx test feasible in cervical cancer

Precision Therapeutics’ ChemoFx test feasible in cervical cancer

Imiquimod and PDT equivalent for superficial basal cell carcinoma

Imiquimod and PDT equivalent for superficial basal cell carcinoma

Prodigy Generics launches injectable irinotecan

Prodigy Generics launches injectable irinotecan

Chemo-radiotherapy combination a viable alternative for frail bladder cancer patients

Chemo-radiotherapy combination a viable alternative for frail bladder cancer patients

CytRx commences INNO-206 Phase 2 clinical trial for pancreatic cancer

CytRx commences INNO-206 Phase 2 clinical trial for pancreatic cancer

UCSD first to treat glioma with investigational viral vector

UCSD first to treat glioma with investigational viral vector

Study finds subtle cognitive deficits in women treated with CMF chemotherapy

Study finds subtle cognitive deficits in women treated with CMF chemotherapy

Regeneron reports total revenues of $123.0M for fourth quarter 2011

Regeneron reports total revenues of $123.0M for fourth quarter 2011

FDA accepts Genentech's pertuzumab BLA and grants Priority Review

FDA accepts Genentech's pertuzumab BLA and grants Priority Review

Mylan acquires two dermatological drugs from Valeant

Mylan acquires two dermatological drugs from Valeant

Valeant divests generic Benzaclin and Efudex to Mylan

Valeant divests generic Benzaclin and Efudex to Mylan